New Scientific Research provides link between Globo-series glycosphingolipids (GSLs) antigens and tumor survival in Breast Cancer

Study supports the anti-Globo series Cancer pipeline under development by OBI Pharma Inc. TAIPEI, TAIWAN / — A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow at Academia Sinica in Taiwan, in collaboration with OBI scientists, has demonstrated in a recent study that the Globo-series glycosphingolipids (GSLs) antigens: Globo-H, SSEA-3, and SSEA-4 are specifically expressed […]

This article is password protected.

To view the content, please enter your password in the field below